gameilluvium| Sales of Maiwei Biosimilars are booming, and revenue is forecast to soar to 2.4 billion yuan in 2024-2026

Date: 5个月前 (04-14)View: 120Comments: 0

[Maiwei Biology recently received positive comments from Huajin Securities.GameilluviumAnd is expected to show significant revenue growth from 2024 to 2026]

On April 13, Maiwei received positive comments from Huajin Securities. In the past month, the company has received attention from three research reports.

These studies predict that Maiwei's revenue will reach 3. 5% respectively in the next three years.Gameilluvium0.68 billion yuan, 1.331 billion yuan and 2.438 billion yuan, with annual growth rates of 188%, 261% and 83%, respectively. Analysts believe that the company's commercial development is stable, the sales prospect of biological similar drugs is promising, and has the potential to achieve rapid growth. In addition, the company's product research and development pipeline is rich, the long-term development potential is huge. At the same time, the company's innovative layout and differentiation strategy in the field of ADC demonstrate its strong R & D strength.

gameilluvium| Sales of Maiwei Biosimilars are booming, and revenue is forecast to soar to 2.4 billion yuan in 2024-2026

However, when paying attention to the growth potential of the company, investors should also pay attention to some potential risks, such as the risk that profits have not yet been realized, the risk that the progress of product research and development falls short of expectations, the uncertainty of product listing approval, the risk that product sales fall short of expectations, and the risk of intensified competition in the bioanalogue market.

Hexun self-selected Stock Writer risk Tip: the above content is only the views of the author or guest, does not represent any position of Hexun, and does not constitute any investment advice related to Hexun. Before making any investment decision, investors should consider the risk factors related to investment products according to their own circumstances and consult professional investment advisers if necessary. Hexun tries its best but cannot confirm the authenticity, accuracy and originality of the above content, and Hexun does not make any guarantee or commitment.

Tags:

Prev: downloadcrashbandicootandroid| The price war continues to haze, and the performance of car dealers declines sharply
Next: tattletales| Xu Haining, Vice President of Orient Securities: Serving and reaching customers should be through a professional service method that accompanies the entire life cycle of the customer, rather than a seller's sales method

Related articlesNo more
︿